Wells Fargo Maintains National Health Investors Inc(NHI.US) With Hold Rating
BofA Securities Maintains National Health Investors Inc(NHI.US) With Buy Rating, Cuts Target Price to $91
Express News | National Health Investors Inc : Jefferies Raises Target Price to $77 From $76
Navigating Risks: National Health Investors' Potential Exposure in Forward Sale Agreements
National Health Investors Inc (NHI) Q3 2024 Earnings Call Highlights: Strategic Investments and ...
National Health Investors, Inc. (NHI) Q3 2024 Earnings Call Transcript Summary
Truist Financial Maintains National Health Investors Inc(NHI.US) With Hold Rating
Wells Fargo Initiates National Health Investors Inc(NHI.US) With Hold Rating, Announces Target Price $86
Analysts Offer Insights on Real Estate Companies: National Health Investors (NHI) and Peakstone Realty Trust (PKST)
Hold Rating Maintained for National Health Investors Amid Financial Uncertainty and Strategic Challenges
National Health Investors Inc To Go Ex-Dividend On December 31st, 2024 With 0.9 USD Dividend Per Share
November 5th (Eastern Time) - $National Health Investors Inc(NHI.US)$ is trading ex-dividend on December 31st, 2024.Shareholders of record on December 31st, 2024 will receive 0.9 USD dividend per
BMO Capital Maintains National Health Investors Inc(NHI.US) With Buy Rating, Maintains Target Price $92
Positive Outlook for National Health Investors Amidst FFO Challenges and Strong SHOP Performance
Express News | National Health Investors Inc: W. Andrew Adams to Retire as Chairperson of Nhi Board, Effective December 31
National Health Investors Lowers 2024 Guidance After Q3 FFO Falls Short
National Health Investors: Q3 Earnings Snapshot
National Health Investors Inc | 10-Q: Q3 2024 Earnings Report
National Health Investors Updates FY24 NAREIT FFO Per Diluted Share From $4.50-$4.54 To $4.39-$4.41; Normalized FFO Per Diluted Share From $4.52-$4.56 To $4.43-$4.44
Earnings Flash (NHI) NATIONAL HEALTH INVESTORS Reports Q3 FFO $1.03
NHI Issues Investor Update